1 Tan W, Xu DY, Xu MJ, et al. The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis[J]. Ther Adv Respir Dis, 2021, 15: 17534666211009407.
2 任成山, 钱桂生. 呼吸衰竭的临床诊断与治疗[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 63-76.
3 Mauri T, Foti G, Fornari C, et al. Sigh in patients with acute hypoxemic respiratory failure and ARDS: The PROTECTION pilot randomized clinical trial[J]. Chest, 2021, 159(4): 1426-1436.
4 Fukuda Y, Tanaka A, Homma T, et al. Utility of SpO2/FiO2 ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU[J]. PLoS One, 2021, 16(1): e0245927.
5 Lu Y, Guo H, Chen X, et al. Association between lactate/albumin ratio and all-cause mortality in patients with acute respiratory failure: A retrospective analysis[J]. PLoS One, 2021, 16(8): e0255744.
6 王 景, 朱述阳, 朱洁晨, 等. 血清超敏C反应蛋白/白蛋白比值预测慢性阻塞性肺疾病急性加重合并呼吸衰竭患者早期再入院的临床价值[J]. 科学技术与工程, 2019, 19(17): 128-132.
7 Gharipour A, Razavi R, Gharipour M, et al. Lactate/albumin ratio: An early prognostic marker in critically ill patients[J]. Am J Emerg Med, 2020, 38(10): 2088-2095.
8 Shadvar K, Nader-Djalal N, Vahed N, et al. Comparison of lactate/albumin ratio to lactate and lactate clearance for predicting outcomes in patients with septic shock admitted to intensive care unit: an observational study[J]. Sci Rep, 2022, 12(1): 13047.
9 Liu Q, Zheng HL, Wu MM, et al. Association between lactate-to-albumin ratio and 28-days all-cause mortality in patients with acute pancreatitis: A retrospective analysis of the MIMIC-Ⅳ database[J]. Front Immunol, 2022, 13: 1076121.
10 Zhu JL, Liu H, Wang LL, et al. Association of lactate to albumin ratio and bicarbonate with short-term mortality risk in patients with acute myocardial infarction[J]. BMC Cardiovasc Disord, 2022, 22(1): 490.
11 任秋艳, 姚惠萍, 罗月月, 等. 不同温度设置对经鼻高流量氧疗急性呼吸衰竭患者的影响[J]. 中华现代护理杂志, 2021, 27(26): 3609-3612.
12 Chalmers SJ, Odeyemi YE, Lal A, et al. F Trajectory as a pragmatic intermediate marker in acute hypoxic respiratory failure[J]. Respir Care, 2021, 66(10): 1521-1530.
13 Kopczynska M, Sharif B, Pugh R, et al. Prevalence and outcomes of acute hypoxaemic respiratory failure in Wales: The PANDORA-WALES study[J]. J Clin Med, 2020, 9(11): 3521-3533.
14 McNamee JJ, Gillies MA, Barrett NA, et al. Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: The REST randomized clinical trial[J]. JAMA, 2021, 326(11): 1013-1023.
15 Pelosi P, Ball L, Barbas CSV, et al. Personalized mechanical ventilation in acute respiratory distress syndrome[J]. Crit Care, 2021, 25(1): 250-259.
16 Alladina J, Levy SD, Cho JL, et al. Plasma soluble suppression of tumorigenicity-2 associates with ventilator liberation in acute hypoxemic respiratory failure[J]. Am J Respir Crit Care Med, 2021, 203(10): 1257-1265.
17 郭 喆, 柴 彦, 方奕鹏, 等. 不同氧合评估法对急性呼吸窘迫综合征的预后评价[J]. 中国急救医学, 2021, 41(11): 966-971.
18 Huber W, Findeisen M, Lahmer T, et al. Prediction of outcome in patients with ARDS: A prospective cohort study comparing ARDS-definitions and other ARDS-associated parameters, ratios and scores at intubation and over time[J]. PLoS One, 2020, 15(5): e0232720.
19 Kao KC, Chang KW, Chan MC, et al. Predictors of survival in patients with influenza pneumonia-related severe acute respiratory distress syndrome treated with prone positioning[J]. Annals of Intensive Care, 2018, 8: 94-102.
20 Prakash J, Bhattacharya PK, Yadav AK, et al. ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: A systematic review and meta-analysis[J]. J Crit Care, 2021, 66:102-108.
21 TalpoS MT, Rasson A, De Terwangne C, et al. Early prediction of high-flow oxygen therapy failure in COVID-19 acute hypoxemic respiratory failure: A retrospective study of scores and thresholds[J]. Cureus, 2022, 14(11): e32087.
22 Carvalho EB, Leite TRS, Sacramento RFM, et al. Rationale and limitations of the SpO2/FiO2 as a possible substitute for PaO2/FiO2 in different preclinical and clinical scenarios[J]. Rev Bras Ter Intensiva, 2022, 34(1): 185-196.
23 Wang G, Liu J, Xu R, et al. Lactate/albumin ratio as a predictor of in-hospital mortality in critically ill children[J]. BMC Pediatr, 2022, 22(1): 725-735.
24 Song H, Moon HG, Kim SH. Efficacy of quick sequential organ failure assessment with lactate concentration for predicting mortality in patients with community-acquired pneumonia in the emergency department[J]. Clin Exp Emerg Med, 2019, 6(1): 1-8.
25 牟厚玲, 韩 平. APACHEⅡ评分及血乳酸清除率在呼吸衰竭患者病情及预后评估的研究[J]. 中国实验诊断学, 2020, 24(2): 230-233.
26 Deng XJ, Zou Y, Wu J, et al. The effect of blood lactate and NT-proBNP predict the survival in patients with invasive mechanical ventilation[J]. Ann Transl Med, 2020, 8(7): 458.
27 李若青, 田继刚, 杨 芳, 等. 2019-新型冠状病毒感染的肺炎患者血清白蛋白浓度与淋巴细胞水平关系的临床研究[J]. 中华急诊医学杂志, 2020, 29(4): 478-482.
28 黄琪惠, 张 琳. 中性粒细胞/淋巴细胞比值、C-反应蛋白/白蛋白及低钙在重症颅脑损伤并早期呼吸机相关性肺炎的价值分析[J]. 实用医学杂志, 2021, 37(7): 903-908.
29 Shi T, Feng L. Blood biomarkers associated with acute type Ⅱ respiratory failure in COPD: A meta-analysis[J]. Clin Respir J, 2022, 16(2): 75-83.
30 Jeong JH, Heo M, Lee SJ, et al. Clinical usefulness of red cell distribution width/albumin ratio to discriminate 28-day mortality in critically Ⅲ patients with pneumonia receiving invasive mechanical ventilation, compared with lacate/albumin ratio: A retrospective cohort study[J]. Diagnostics(Basel), 2021, 11(12): 2344.